Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage

Neurosurgery

Volumn 64, Issue 3, 2009, Pages 423-428

  Munakata, Akira ^a   Ohkuma, Hiroki ^a   Nakano, Takahiro ^a   Shimamura, Norihito ^a   Asano, Kenichirou ^a   Naraoka, Masato ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Cerebral aneurysm; Cerebral vasospasm; Edaravone; Free radical scavenger; Subarachnoid hemorrhage

Indexed keywords

FASUDIL; FLUDROCORTISONE ACETATE; FREE RADICAL; HYDROCORTISONE SODIUM SUCCINATE; NORPHENAZONE; PAPAVERINE;

ADULT; ARTICLE; BLOOD CLOT; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED ISCHEMIC NEUROLOGIC DEFICIT; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID HEMORRHAGE;

ANTIPYRINE; CEREBRAL INFARCTION; COMORBIDITY; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; JAPAN; MALE; MIDDLE AGED; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 62849108201     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000338067.83059.EB     Document Type: Article

References (40)

1. Asano T, Takakura K, Sano K, Kikuchi H, Nagai H, Saito I, Tamura A, Ochiai C, Sasaki T: Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial. J Neurosurg 84:792-803, 1996.
2. Echlin F: Experimental vasospasm, acute and chronic, due to blood in the subarachnoid space. J Neurosurg 35:646-656, 1971.
3. Edaravone Acute Brain Infarction Study Group: Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 15:222-229, 2003.
4. Finn SS, Stephensen SA, Miller CA, Drobnich L, Hunt WE: Observations on the perioperative management of aneurysmal subarachnoid hemorrhage. J Neurosurg 65:48-62, 1986.
5. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1-9, 1980.
6. Haley EC Jr, Kassell NF, Alves WM, Weir BK, Hansen CA: Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. J Neurosurg 82:786-790, 1995.
7. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America. J Neurosurg 86:467-174, 1997.
8. Hashi K, Takakura K, Sano K, Ohta T, Saito I, Okada K: Intravenous hydrocortisone in large doses in the treatment of delayed ischemic neurological deficits following subarachnoid hemorrhage - Results of a multi-center controlled double-blind clinical study [in Japanese]. No To Shinkei 40:373-382, 1988.
9. Hunt WE, Hess RM: Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg 28: 14-20, 1968.
10. Iwabuchi S, Yokouchi T, Hayashi M, Uehara H, Ueda M, Samejima H: Intraarterial administration of fasudil hydrochloride for vasospasm following subarachnoid hemorrhage - Analysis of time-density curve with digital subtraction angiography. Neurol Med Chir (Tokyo) 46:535-540, 2006.
11. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K: Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 77:842-847, 1992.
12. Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996.
13. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS: Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 77:848-852, 1992.
14. Kassell NF, Peerless SJ, Durward QJ, Beck DW, Drake CG, Adams HP: Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension. Neurosurgery 11:337-343, 1982.
15. Kassell NF, Sasaki T, Colohan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16:562-572, 1985.
16. Kinoshita Y, Terada T, Nakamura Y, Nakai E, Nakai K, Itakura T, Naka Y, Naka D, Takehara R, Imai H: Endovascular treatment of cerebral vasospasm with intra-arterial papaverine infusion [in Japanese]. No Shinkei Geka 23:881-887, 1995.
17. Lanzino G, Kassell NF: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024, 1999.
18. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, Truskowski LL, Alves WM: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017, 1999.
19. Macdonald RL, Weir BK: A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 22:971-982, 1991.
20. Macdonald RL, Weir BK: Cerebral vasospasm and free radicals. Free Radic Biol Med 16:633-643, 1994.
21. Macdonald RL, Weir BK, Runzer TD, Grace MG, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K: Etiology of cerebral vasospasm in primates. J Neurosurg 75:415-424, 1991.
22. Matsui T, Kaizu H, Itoh S, Asano T: The role of active smooth-muscle contraction in the occurrence of chronic vasospasm in the canine two-hemorrhage model. J Neurosurg 80:276-282, 1994.
23. Matsui T, Sugawa M, Johshita H, Takuwa Y, Asano T: Activation of the protein kinase C-mediated contractile system in canine basilar artery undergoing chronic vasospasm. Stroke 22:1183-1187, 1991.
24. Matsui T, Takuwa Y, Johshita H, Yamashita K, Asano T: Possible role of protein kinase C-dependent smooth muscle contraction in the pathogenesis of chronic cerebral vasospasm. J Cereb Blood Flow Metab 11:143-149, 1991.
25. Mayberg MR, Okada T, Bark DH: The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 72:634-640, 1990.
26. Minami H, Kuwamura K, Tamaki N: Intraarterial infusion of papaverine and change of cerebral hemodynamics in symptomatic cerebral vasospasm. Kobe J Med Sci 47:169-179, 2001.
27. Mori T, Katayama Y, Kawamata T, Hirayama T: Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 91:947-952, 1999.
28. Nakagomi T, Yamakawa K, Sasaki T, Saito I, Takakura K: Effect of edaravone on cerebral vasospasm following experimental subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 12:17-21, 2003.
29. Saito I, Asano T, Sano K, Takakura K, Abe H, Yoshimoto T, Kikuchi H, Ohta T, Ishibashi S: Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42:269-278, 1998.
30. Sako M, Nishihara J, Ohta S, Wang J, Sakaki S: Role of protein kinase C in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13:247-254, 1993.
31. Sato M, Tani E, Fujikawa H, Kaibuchi K: Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res 87:195-200, 2000.
32. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg 76:571-577, 1992.
33. Steele JA, Stockbridge N, Maljkovic G, Weir B: Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Circ Res 68:416-423, 1991.
34. Takuwa Y, Matsui T, Abe Y, Nagafuji T, Yamashita K, Asano T: Alterations in protein kinase C activity and membrane lipid metabolism in cerebral Vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab 13:409-415, 1993.
35. Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84, 1974.
36. Watanabe Y, Faraci FM, Heistad DD: Activation of Rho-associated kinase during augmented contraction of the basilar artery to serotonin after subarachnoid hemorrhage. Am J Physiol 288:H2653-H2658, 2005.
37. Weir B, MacDonald L: Cerebral vasospasm. Clin Neurosurg 40:40-55, 1993.
38. Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, Xu B, Wang R: Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 46:421-428, 2006.
39. Zhang JH: Role of protein kinase C in cerebral vasospasm: Past and future. Neurol Res 22:369-378, 2000.
40. Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T: Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke 36:2220-2225, 2005.